Neuropsychopharmacology of psychosis: Relation of brain signals, cognition, and chemistry

Frontiers in Psychiatry

Volumn 5, Issue JUL, 2014, Pages

  Schmidt, André ^a   Borgwardt, Stefan ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Brain connectivity; Cognition; Computational psychiatry; Neuroimaging; Pharmacology; Psychosis; Psychosis high risk state

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

BRAIN LEVEL; BRAIN SIGNAL; COGNITION; COGNITIVE DEFECT; DISEASE ASSOCIATION; EDITORIAL; ELECTROENCEPHALOGRAPHY; GLUTAMATERGIC METABOLITE; HUMAN; MAGNETOENCEPHALOGRAPHY; METABOLITE; NEAR INFRARED SPECTROSCOPY; NERVOUS SYSTEM PARAMETERS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOPHARMACOLOGY; PSYCHOSIS; SCHIZOPHRENIA;

EID: 84904470158     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2014.00076     Document Type: Editorial

References (22)

1. Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 70(1):107-20. doi: 10.1001/jamapsychiatry.2013.269
2. Schmidt A, Smieskova R, Aston J, Simon A, Allen P, Fusar-Poli P, et al. Brain connectivity abnormalities predating the onset of psychosis: correlation with the effect of medication. JAMA Psychiatry (2013) 70(9):903-12. doi:10.1001/jamapsychiatry.2013.117
3. Fusar-Poli P, Deste G, Smieskova R, Barlati S, Yung A, Howes O, et al. Cognitive functioning in prodromal psychosis: a meta-analysis cognitive functioning in prodromal psychosis. Arch Gen Psychiatry (2012) 69(6):562-71. doi:10.1001/archgenpsychiatry.2011.1592
4. Kuswanto CN, Sum MY, Sim K. Neurocognitive functioning in schizophrenia and bipolar disorder: clarifying concepts of diagnostic dichotomy vs. continuum. Front Psychiatry (2013) 4:162. doi:10.3389/fpsyt.2013.00162
5. Ayesa-Arriola R, Roiz-Santiáñez R, Pérez-Iglesias R, Ferro A, Sainz J, Crespo-Facorro B. Neuroanatomical differences between first-episode psychosis patients with and without neurocognitive deficit: a 3-year longitudinal study. Front Psychiatry (2013) 4:134. doi:10.3389/fpsyt.2013.00134
6. Ziermans TB. Working memory capacity and psychotic-like experiences in a general population sample of adolescents and young adults. Front Psychiatry (2013) 4:161. doi:10.3389/fpsyt.2013.00161
7. Koike S, Nishimura Y, Takizawa R, Yahata N, Kasai K. Near-infrared spectroscopy in schizophrenia: a possible biomarker for predicting clinical outcome and treatment response. Front Psychiatry (2013) 4:145. doi:10.3389/fpsyt.2013.00145
8. Kroken RA, Løberg EM, Drønen T, Grüner R, Hugdahl K, Kompus K, et al. A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation. Front Psychiatry (2014) 5:11. doi:10.3389/fpsyt.2014.00011
9. Vingerhoets WA, Bloemen OJ, Bakker G, van Amelsvoort TA. Pharmacological interventions for the MATRICS cognitive domains in schizophrenia: what's the evidence? Front Psychiatry (2013) 4:157. doi:10.3389/fpsyt.2013.00157
10. Merritt K, McGuire P, Egerton A. Relationship between glutamate dysfunction and symptoms and cognitive function in psychosis. Front Psychiatry (2013) 4:151. doi:10.3389/fpsyt.2013.00151
11. Lakhan SE, Caro M, Hadzimichalis N. NMDA receptor activity in neuropsychiatric disorders. Front Psychiatry (2013) 4:52. doi:10.3389/fpsyt.2013.00052
12. Gruber O, Chadha Santuccione A, Aach H. Magnetic resonance imaging in studying schizophrenia, negative symptoms, and the glutamate system. Front Psychiatry (2014) 5:32. doi:10.3389/fpsyt.2014.00032
13. Lee H, Dvorak D, Fenton AA. Targeting neural synchrony deficits is sufficient to improve cognition in a schizophrenia-related neurodevelopmental model. Front Psychiatry (2014) 5:15. doi:10.3389/fpsyt.2014.00015
14. Todd J, Harms L, Schall U, Michie PT. Mismatch negativity: translating the potential. Front Psychiatry (2013) 4:171. doi:10.3389/fpsyt.2013.00171
15. Bodatsch M, Klosterkötter J, Daumann J. Contributions of experimental psychiatry to research on the psychosis prodrome. Front Psychiatry (2013) 4:170. doi:10.3389/fpsyt.2013.00170
16. Mathalon DH, Ahn KH, Perry EB, Cho HS, Roach BJ, Blais RK, et al. Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans. Front Psychiatry (2014) 5:3. doi:10.3389/fpsyt.2014.00003
17. Adams RA, Stephan KE, Brown HR, Frith CD, Friston KJ. The computational anatomy of psychosis. Front Psychiatry (2013) 4:47. doi:10.3389/fpsyt.2013.00047
18. Dauvermann MR, Whalley HC, Schmidt A, Lee GL, Romaniuk L, Roberts N, et al. Computational neuropsychiatry - schizophrenia as a cognitive brain network disorder. Front Psychiatry (2014) 5:30. doi:10.3389/fpsyt.2014.00030
19. Anticevic A, Cole MW, Repovs G, Savic A, Driesen NR, Yang G, et al. Connectivity, pharmacology, and computation: toward a mechanistic understanding of neural system dysfunction in schizophrenia. Front Psychiatry (2013) 4:169. doi:10.3389/fpsyt.2013.00169
20. Deserno L, Boehme R, Heinz A, Schlagenhauf F. Reinforcement learning and dopamine in schizophrenia: dimensions of symptoms or specific features of a disease group? Front Psychiatry (2013) 4:172. doi:10.3389/fpsyt.2013.00172
21. Roiser JP, Wigton R, Kilner JM, Mendez MA, Hon N, Friston KJ, et al. Dysconnectivity in the frontoparietal attention network in schizophrenia. Front Psychiatry (2013) 4:176. doi:10.3389/fpsyt.2013.00176
22. Diwadkar V, Bakshi N, Gupta G, Pruitt P, White R, Eickhoff S. Dysfunction and dysconnection in cortical-striatal networks during sustained attention: genetic risk for schizophrenia or bipolar disorder and its impact on brain network function. Front Psychiatry (2014) 5:50. doi:10.3389/fpsyt.2014.00050